Tianyin Pharma (TPI) Reports Q3 EPS of $0.03; Cuts FY12 Outlook
Tweet
Share
E-mailGet Alerts TPI Hot Sheet
Join SI Premium – FREE
Tianyin Pharmaceutical (NYSE: TPI) reported Q3 EPS of $0.03, versus $0.14 reported last year. Revenue for the quarter came in at $14.4 million, versus $24.9 million reported last year.
Sees FY2012 revenue of $66 million, versus prior guidance of $100 million and the consensus of $100.20 million. The company is now expecting net income of $6.5 million, down from $10 million previously.
For earnings history and earnings-related data on Tianyin Pharmaceutical (TPI) click here.
Sees FY2012 revenue of $66 million, versus prior guidance of $100 million and the consensus of $100.20 million. The company is now expecting net income of $6.5 million, down from $10 million previously.
For earnings history and earnings-related data on Tianyin Pharmaceutical (TPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
